Evidence map›Paper›PMID 42038160›Full record

ArticleHealth science reports2026

Robustness of Joint Over Separate Models for Investigating Predictors of Blood Sugar Level and Time to First Remission Among Type I Diabetic Patients Under Treatment; a Retrospective Study Design.

Maru Zewdu Kassie, Awoke Seyoum Tegegne

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maru Zewdu KassieDepartment of Statistics, College of Natural and Computational Sciences Assosa University Assosa Ethiopia.ORCID https://orcid.org/0000-0001-5291-9623
Awoke Seyoum TegegneDepartment of Statistics, College of Science Bahir Dar University Bahir Dar Ethiopia.ORCID https://orcid.org/0000-0001-9132-8025

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Diabetes mellitus (DM) is a major public health problem that is responsible for morbidity and mortality. Blood sugar levels in DM patients fluctuate based on self-care management, influencing survival biomarkers such as death, complications, and recovery. A joint modeling approach was used to evaluate the relationship between these biomarkers, including their longitudinal trajectories and the corresponding survival times. The study aimed to identify factors affecting longitudinal blood sugar level measurements and time to first remission in T1DM patients at Debre Tabor General Hospital, Northwest Ethiopia. Methods: A retrospective study was conducted on 217 randomly selected T1DM patients from January 2018 to January 2020. The linear mixed model for the longitudinal part, the Cox PH model for the survival part, and the joint model for their association were used. The Kaplan-Meier survival estimate and Log-Rank test were utilized to assess and compare the survival times. Results: In the current study, about 67.7% of the patients had their first remission, and the rest 32.3% were censored. The estimate of the unobserved association parameter ( Conclusion: The joint model outperforms the separate model in terms of variability, goodness of fit, and statistical significance. Future studies should use joint modeling for longitudinal and survival data analysis. Targeted interventions for risk factors like age, gender, comorbidities, family history, and anemia may enhance remission and glycemic control.

Indexed as

blood sugar levelCox proportional hazard modelJoint modellinear mixed modeltime to first remission

Identifiers

PMID42038160
PMCPMC13109078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.